Today: 6 June 2026
Browse Category

OTC:NRXS 24 October 2025

NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

NeurAxis announced FDA 510(k) clearance for its PENFS device to treat adult functional dyspepsia on Oct. 24, marking the first approved therapy for this condition. NRXS shares rose to $3.82 on Oct. 23 and traded higher pre-market after the news. The company recently raised $5 million and expanded insurance coverage to 53 million lives. Q2 revenue grew 46% year-over-year; analyst sentiment remains mixed.
24 October 2025
··

Stock Market Today

  • Adecoagro (AGRO) Shares Fall 17% in One Month Amid Mixed Earnings and Growth Prospects
    June 6, 2026, 4:07 AM EDT. Adecoagro's (AGRO) stock declined about 17% in the past month following a strong 47% year-to-date gain, reflecting investor reassessment of growth and risks. The South American agribusiness, with $1.5 billion annual revenue and $13.7 million net income, spans sugar, ethanol, energy, and fertilizers. Trading around $11.42, the stock is considered roughly 12% undervalued versus a $12.91 fair value estimate, supported by operational investments to boost flexibility between sugar and ethanol production. Policy tailwinds like Brazil's E30 ethanol mandate and tight market supplies could enhance margins and revenues. However, risks remain from climate variability and unhedged commodity prices. Investors weigh these factors amid a mixed earnings outlook and the potential for future growth.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 06.06.2026

6 June 2026
LIVEMarkets rolling coverageStarted: June 6, 2026, 4:00 AM EDTUpdated: June 6, 2026, 4:21 AM EDT Adecoagro (AGRO) Shares Fall 17% in One Month Amid Mixed Earnings and Growth Prospects June 6, 2026, 4:07 AM EDT. Adecoagro’s (AGRO) stock declined about 17% in the past month following a strong 47% year-to-date gain, reflecting investor reassessment of growth and risks. The South American agribusiness, with $1.5 billion annual revenue and $13.7 million net income, spans sugar, ethanol, energy, and fertilizers. Trading around $11.42, the stock is considered roughly 12% undervalued versus a $12.91 fair value estimate, supported by operational investments to boost
Rigetti Stock Drops After Quantum Surge Stalls on Wall Street Rate Jolt

Rigetti Stock Drops After Quantum Surge Stalls on Wall Street Rate Jolt

6 June 2026
Rigetti Computing plunged 14.5% to $20.68 as tech stocks tumbled after strong May payrolls fueled fears of prolonged high U.S. rates, pressuring long-duration names; the selloff highlights risks tied to government funding, potential equity dilution, and uncertain commercial milestones, with Rigetti posting a $26 million Q1 operating loss and $4.4 million revenue despite recent product and funding announcements.
POET Technologies Stock Drops Sharply as Investors Watch

POET Technologies Stock Drops Sharply as Investors Watch

6 June 2026
POET Technologies plunged 23% to $11.86 amid a semiconductor selloff, as investors weighed execution risks after a $400 million capital raise, a $50 million Lumilens order, and recent turbulence from Marvell’s canceled purchase orders, with dilution and tax-status questions adding pressure.
Flex grabs S&P 500 spot but shares drop

Flex grabs S&P 500 spot but shares drop

6 June 2026
Flex will join the S&P 500 on June 22, drawing investor focus to its surging AI data-center power unit and planned spin-off, even as shares fell 4.8% to $151.92 amid a tech selloff; CPI sales jumped 38% to $6.61 billion in fiscal 2026, now 24% of total revenue, but margin slipped 100 basis points due to ramp-up costs and product mix.
Intel shares hit as AI chip slump wipes out $1.3 trillion

Intel shares hit as AI chip slump wipes out $1.3 trillion

6 June 2026
Intel plunged 11.4% to $99.17 on heavy volume as the PHLX Semiconductor Index suffered its worst drop since March 2020, wiping out $1.3 trillion in U.S. chipmaker market value, overshadowing Intel’s new AI partnership with Foxconn amid sector-wide selling triggered by Broadcom’s guidance and renewed Fed rate hike fears.
Go toTop